FrancophonIA/ELRC3.0 huggingface dataset:
English: When transferring a patient from biphasic human insulin to NovoMix 30, start with the same dose and regimen.
Estonian: Patsiendi üleviimisel bifaasiliselt humaaninsuliinilt insuliinile NovoMix 30 alustage sama annuse ja raviskeemiga, seejärel tiitrige individuaalsetest vajadustest lähtudes (vt tiitrimisjuhised ülaltoodud tabelis).
English: NovoMix 70 is a mixture consisting of 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine.
Estonian: NovoMix 70 on segu, mis koosneb 70% lahustuvast aspartinsuliinist ja 30% protamiiniga kristalliseeritud aspartinsuliinist.
English: On rare occasions, injection site reactions may require discontinuation of NovoMix 50.
Estonian: Harvadel juhtudel nõuavad süstekoha reaktsioonid NovoMix 50 ravi lõpetamist.
English: NovoMix 70 is for subcutaneous administration only.
Estonian: NovoMix 70 manustatakse ainult subkutaanselt.
English: How to use NovoMix 30
Estonian: Kuidas NovoMix 30 kasutada
English: The necessity of resuspending the NovoMix 50 suspension immediately before use is to be stressed to the patient.
Estonian: Patsiendile tuleb rõhutada vajadust resuspendeerida NovoMix 50 suspensioon vahetult enne kasutamist.
English: NovoMix 70 is for injection under the skin (subcutaneously).
Estonian: NovoMix 70 süstitakse naha alla (subkutaanselt).
English: The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 50/50.
Estonian: Suspensioon sisaldab kiiretoimelist ja keskmise toimeajaga aspartinsuliini vahekorras 50/50.
English: Serious allergic reactions to NovoMix 30 or one of its ingredients (called a systemic allergic reaction) is a very rare side effect, but it can potentially be life-threatening.
Estonian: Tõsine allergiline reaktsioon NovoMix 30 või mõne selle koostises oleva aine suhtes (nimetatakse süsteemseks allergiliseks reaktsiooniks).
English: 10 x 3 ml cartridges
Estonian: 10 kolbampulli x 3 ml
English: The necessity of resuspending the NovoMix 30 suspension immediately before use is to be stressed to the patient.
Estonian: Patsiendile tuleb rõhutada vajadust resuspendeerida NovoMix 30 suspensioon vahetult enne kasutamist.
English: How to use NovoMix 70
Estonian: Kuidas NovoMix 70 kasutada
English: L ► Keep the push-button fully depressed and let the needle remain under the skin for at least
Estonian: L ► Hoidke süstenupp lõpuni all ja jätke nõel naha alla vähemalt 6 sekundiks.
English: Always keep the cartridge in the outer carton when you are not using it, in order to protect it from light.
Estonian: Kõlblikkusaeg viitab kuu viimasele päevale.Kui te kolbampulli ei kasuta, siis hoidke seda alati välispakendis valguse eest kaitstult.
English: When necessary, NovoMix 30 can be given soon after a meal.
Estonian: Vajadusel võib NovoMix 30 manustada varsti pärast sööki.
English: In healthy volunteers, a mean maximum serum concentration of 445 ± 135 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.30 unit/kg body weight.
Estonian: Tervetel vabatahtlikel saabus keskmine maksimaalne seerumikontsentratsioon (445 ± 135 pmol/l) umbes 60 minutit pärast subkutaanse annuse 0,30 ühikut/kehakaalu kg kohta manustamist.
English: How to use NovoMix 50
Estonian: Kuidas NovoMix 50 kasutada
English: Do not use the insulin, if it does not look uniformly white, cloudy and aqueous after resuspension.
Estonian: Ärge kasutage insuliini, kui see ei ole ühtlaselt valge ja hägune vesisuspensioon.
English: NovoMix 70 is a biphasic suspension of 70% soluble insulin aspart (rapid-acting human insulin analogue) and 30% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue).
Estonian: NovoMix 70 on 70% lahustuva aspartinsuliini (kiiretoimelise humaaninsuliini analoog) ja 30% protamiiniga kristalliseeritud aspartinsuliini (keskmise toimeajaga humaaninsuliini analoog) bifaasiline suspensioon.
English: 5 x 3 ml cartridges
Estonian: 5 kolbampulli x 3 ml
English: NovoMix 30 is a mixture consisting of 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine.
Estonian: NovoMix 30 on segu, mis koosneb 30% lahustuvast aspartinsuliinist ja 70% protamiiniga kristalliseeritud aspartinsuliinist.
English: On rare occasions, injection site reactions may require discontinuation of NovoMix 30.
Estonian: Harvadel juhtudel nõuavad süstekoha reaktsioonid NovoMix 30 ravi lõpetamist.
English: 1 x 3 ml cartridge 5 x 3 ml cartridges 10 x 3 ml cartridges
Estonian: 1 kolbampull x 3 ml 5 kolbampulli x 3 ml 10 kolbampulli x 3 ml
English: Resuspension of NovoMix 50
Estonian: NovoMix 50 resuspendeerimine
English: NovoMix 50 is for injection under the skin (subcutaneously).
Estonian: NovoMix 50 süstitakse naha alla (subkutaanselt).
English: In patients with type 2 diabetes, a meta-analysis showed a reduced risk of overall nocturnal hypoglycaemic episodes and major hypoglycaemia with NovoMix 30 compared to biphasic human insulin 30.
Estonian: Metaanalüüs näitas öise hüpoglükeemia ja raske hüpoglükeemia juhtude koguarvu vähenemist II tüüpi diabeediga patsientidel NovoMix 30 ravi tulemusena võrrelduna bifaasilist humaaninsuliini 30 saanutega.
English: Figure 1: Activity Profile for NovoMix 70 in Healthy Caucasian Subjects.
Estonian: NovoMix 70 toime profiil tervetel europiidse rassi esindajatel.
English: NovoMix 30 is for injection under the skin (subcutaneously).
Estonian: NovoMix 30 süstitakse naha alla (subkutaanselt).
English: ► If you are treated with NovoMix 50 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
Estonian: ► Kui kasutate raviks NovoMix 50 Penfill'i ja mõne teise insuliini kolbampulli, peate kasutama kummagi insuliini jaoks eraldi süstevahendit.
English: Picture A
Estonian: Joonis B
English: NovoMix 70 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 70/30.
Estonian: NovoMix 70 FlexPen on värviga märgistatud, eeltäidetud, ühekordseks kasutamiseks mõeldud pensüstel, mis sisaldab kiiretoimelise ja keskmise toimeajaga aspartinsuliini segu vahekorras 70/30.
English: Resuspension of NovoMix 70
Estonian: NovoMix 70 resuspendeerimine
English: After removing NovoMix 30 Penfill or NovoMix 30 FlexPen from the refrigerator, it is recommended to allow NovoMix 30 Penfill or NovoMix 30 FlexPen to reach room temperature before resuspending the insulin as instructed for first time use.
Estonian: 6.6 Erihoiatused ravimi hävitamiseks ja käsitlemiseks On soovituslik lasta külmkapist võetud NovoMix 30 Penfill'il või NovoMix 30 FlexPen'il saavutada toatemperatuur enne resuspendeerimist vastavalt esmakordse kasutamise juhistele.
English: PHARMACEUTICAL FORM AND CONTENTS Suspension for injection
Estonian: RAVIMVORM JA PAKENDI SUURUS Süstesuspensioon.
English: In healthy volunteers, a mean maximum serum concentration of 645 ± 185 pmol/l was reached about 60 minutes after a subcutaneous dose of 0.30 unit/kg body weight.
Estonian: Tervetel vabatahtlikel saabus keskmine maksimaalne seerumikontsentratsioon (645 ± 185 pmol/l) umbes 60 minutit pärast subkutaanse annuse 0,30 ühikut/kehakaalu kg kohta manustamist.
English: ► If you are treated with NovoMix 30 Penfill and another insulin Penfill cartridge, you should use two insulin delivery systems, one for each type of insulin.
Estonian: ► Kui kasutate raviks NovoMix 30 Penfill'i ja mõne teise insuliini kolbampulli, peate kasutama kummagi insuliini jaoks eraldi süstevahendit.
English: NovoMix 50 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 50/50.
Estonian: NovoMix 50 on nüüdisaegne insuliin (analooginsuliin), milles lühikese toimeajaga ja keskmise toimeajaga insuliini suhe on 50/50.
English: How to handle NovoMix 70 FlexPen
Estonian: Kuidas NovoMix 70 FlexPen'i käsitseda
English: NovoMix 30 is a biphasic suspension of 30% soluble insulin aspart (rapid-acting human insulin analogue) and 70% protamine-crystallised insulin aspart (intermediate-acting human insulin analogue).
Estonian: NovoMix 30 on 30% lahustuva aspartinsuliini (kiiretoimelise humaaninsuliini analoog) ja 70% protamiiniga kristalliseeritud aspartinsuliini (keskmise toimeajaga humaaninsuliini analoog) bifaasiline suspensioon.
English: Figure 1: Activity Profile for NovoMix 50 in Healthy Caucasian Subjects.
Estonian: NovoMix 50 toime profiil tervetel europiidse rassi esindajatel.
English: How to handle NovoMix 50 FlexPen
Estonian: Kuidas NovoMix 50 FlexPen'i käsitseda
English: NovoMix 70 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 70/30.
Estonian: NovoMix 70 on nüüdisaegne insuliin (analooginsuliin), milles lühikese toimeajaga ja keskmise toimeajaga insuliini suhe on 70/30.
English: If any of these apply, do not use NovoMix 50.
Estonian: Ülaltoodud juhtudel ärge NovoMix 50 kasutage.
English: No data are available for NovoMix 30 in children below 6 years of age.
Estonian: Andmed NovoMix 30 kasutamise kohta alla 6-aastastel lastel puuduvad.
English: Pushbutton
Estonian: NovoTwist.
English: NovoMix 30 FlexPen is a pre-filled, colour-coded, disposable pen containing a mixture of rapid-acting and intermediate-acting insulin aspart in the ratio 30/70.
Estonian: NovoMix 30 FlexPen on värviga märgistatud, eeltäidetud, ühekordseks kasutamiseks mõeldud pensüstel, mis sisaldab kiiretoimelise ja keskmise toimeajaga aspartinsuliini segu vahekorras 30/70.
English: NAME OF THE MEDICINAL PRODUCT NovoMix 70 Penfill 100 units/ml suspension for injection in cartridge NovoMix 70 FlexPen 100 units/ml suspension for injection in pre-filled pen
Estonian: RAVIMPREPARAADI NIMETUS NovoMix 70 Penfill 100 ühikut/ml süstesuspensioon kolbampullis NovoMix 70 FlexPen 100 ühikut/ml süstesuspensioon pen-süstlis
English: Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity and toxicity to reproduction and development.
Estonian: Farmakoloogilise ohutuse, kroonilise toksilisuse, genotoksilisuse, reproduktsioonitoksilisuse ja arengu mittekliinilised uuringud ei ole näidanud kahjulikku toimet inimesele.
English: The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 30/70.
Estonian: Suspensioon sisaldab kiiretoimelist ja keskmise toimeajaga aspartinsuliini vahekorras 30/70.
English: Discard the needle after each injection
Estonian: Pärast iga süstimist visake nõel ära.
English: If any of these apply, do not use NovoMix 30.
Estonian: Ülaltoodud juhtudel ärge NovoMix 30 kasutage.
English: ► FlexPen is designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm. ► Always carry a spare insulin delivery device in case your FlexPen is lost or damaged.
Estonian: ► FlexPen on ette nähtud kasutamiseks kuni 8 mm ühekordsete nõeltega NovoFine või
English: When NovoMix 70 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.
Estonian: NovoMix 70 süstimisel naha alla avaldub toime 10...20 minuti möödudes.
English: Always ensure you use the correct pen before you inject your insulin.
Estonian: Enne insuliini süstimist veenduge alati, et kasutate õiget süstevahendit.
English: ► Needles and NovoMix 50 FlexPen must not be shared.
Estonian: ► Nõelad ja NovoMix 50 FlexPen on individuaalseks kasutamiseks.
English: NovoMix 30 FlexPen Glass ball
Estonian: NovoMix 30 FlexPen Klaas kuul Kolbampull
English: When NovoMix 50 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.
Estonian: NovoMix 50 süstimisel naha alla avaldub toime 10...20 minuti möödudes.
English: NovoMix 30 is a modern insulin (insulin analogue) with both a rapid-acting and an intermediateacting effect, in the ratio 30/70.
Estonian: NovoMix 30 on nüüdisaegne insuliin (analooginsuliin), milles lühikese toimeajaga ja keskmise toimeajaga insuliini suhe on 30/70.
English: ► Needles and NovoMix 70 FlexPen must not be shared.
Estonian: ► Nõelad ja NovoMix 70 FlexPen on individuaalseks kasutamiseks.
English: How to store NovoMix 50
Estonian: Kuidas süstida NovoMix 50
English: NAME OF THE MEDICINAL PRODUCT NovoMix 50 Penfill 100 units/ml suspension for injection in cartridge NovoMix 50 FlexPen 100 units/ml suspension for injection in pre-filled pen
Estonian: RAVIMPREPARAADI NIMETUS NovoMix 50 Penfill 100 ühikut/ml süstesuspensioon kolbampullis NovoMix 50 FlexPen 100 ühikut/ml süstesuspensioon pen-süstlis
English: • If the second and third characters are H7 or T6, the manufacturer is Novo Nordisk Production
Estonian: A/S, Novo Allé, DK-2880 Bagsværd, Taani - Kui teine ja kolmas kirjamärk on H7 või T6, on tootjaks Novo Nordisk Production SAS, 45
English: How to handle NovoMix 30 FlexPen
Estonian: Kuidas NovoMix 30 FlexPen'i käsitseda
English: Pack sizes of 1, 5 and 10 pre-filled pens.
Estonian: Pakendi suurused 1, 5 või 10 pen-süstlit.
English: NovoMix 70 is a biphasic suspension of the insulin analogue, insulin aspart.
Estonian: NovoMix 70 on analooginsuliini aspartinsuliin bifaasiline suspensioon.
English: NovoMix 50 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14-24 hours.
Estonian: NovoMix 50 veresuhkrut langetav toime algab 10...20 minutit pärast süstimist, saavutab maksimumi 1...4 tunni jooksul pärast süstimist ning kestab 14…24 tundi.
English: Pack sizes of 5 and 10 cartridges.
Estonian: Pakendi suurused 5 või 10 kolbampulli.
English: NovoMix 50 is for subcutaneous administration only.
Estonian: NovoMix 50 manustatakse ainult subkutaanselt.
English: • Glucocorticoids (such as ‘cortisone' used to treat inflammation)
Estonian: • glükokortikoide (näiteks kortisooni põletiku raviks)
English: The pharmacokinetics of NovoMix 30 have not been investigated in elderly patients or in patients with renal or hepatic impairment.
Estonian: NovoMix 30 farmakokineetikat ei ole uuritud eakatel ja neeru- või maksafunktsiooni häirega patsientidel.
English: INFORMATION IN BRAILLE NovoMix 70 Penfill
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 70 Penfill
English: NovoMix 30 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 24 hours.
Estonian: NovoMix 30 veresuhkrut langetav toime algab 10...20 minutit pärast süstimist, saavutab maksimumi 1...4 tunni jooksul pärast süstimist ning kestab kuni 24 tundi.
English: ► Needles and NovoMix 30 FlexPen must not be shared.
Estonian: ► Nõelad ja NovoMix 30 FlexPen on individuaalseks kasutamiseks.
English: NovoMix 70 Penfill 100 units/ml
Estonian: NovoMix 70 Penfill 100 ühikut/ml
English: The suspension contains rapid-acting and intermediate-acting insulin aspart in the ratio 70/30.
Estonian: Suspensioon sisaldab kiiretoimelist ja keskmise toimeajaga aspartinsuliini vahekorras 70/30.
English: When NovoMix 30 is injected subcutaneously, the onset of action will occur within 10 to 20 minutes of injection.
Estonian: NovoMix 30 süstimisel naha alla avaldub toime 10...20 minuti möödudes.
English: NovoMix 30 is a biphasic suspension of the insulin analogue, insulin aspart.
Estonian: NovoMix 30 on analooginsuliini aspartinsuliin bifaasiline suspensioon.
English: NovoMix 70 FlexPen Glass ball
Estonian: NovoMix 70 FlexPen Klaas kuul
English: The crystalline phase (70%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin.
Estonian: Kristalliline faas (70%) koosneb protamiiniga kristalliseeritud aspartinsuliinist, mille toime sarnaneb NPH humaaninsuliini toimega.
English: Patients transferred to NovoMix 50 from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products.
Estonian: Üleminek teiselt insuliinitüübilt NovoMix 50 võib patsiendile kaasa tuua suurema süstide arvu päevas või harjumuspärase insuliiniannuse muutmise.
English: NovoMix 30 is for subcutaneous administration only.
Estonian: NovoMix 30 manustatakse ainult subkutaanselt.
English: NovoMix 50 is a biphasic suspension of the insulin analogue, insulin aspart.
Estonian: NovoMix 50 on analooginsuliini aspartinsuliin bifaasiline suspensioon.
English: How to store NovoMix 70
Estonian: Kuidas süstida NovoMix 70
English: INFORMATION IN BRAILLE NovoMix 70 FlexPen
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 70 FlexPen
English: INFORMATION IN BRAILLE NovoMix 50 FlexPen
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 50 FlexPen
English: NovoMix 70 FlexPen 100 units/ml
Estonian: NovoMix 70 FlexPen 100 ühikut/ml
English: There are no restrictions on treatment with NovoMix 70 during breast-feeding.
Estonian: Imetamise ajal ei ole piiranguid ravile NovoMix 70.
English: The occurrence of generalised hypersensitivity reactions (including generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure) is very rare but can potentially be life-threatening.
Estonian: Üldise ülitundlikkuse tunnusteks võivad olla ulatuslik nahalööve, kihelemine, higistamine, gastrointestinaalsed häired, angioneurootiline turse, hingamisraskused, südamepekslemine ja vererõhu langus.
English: NovoMix 70 will start to lower your blood sugar 10-20 minutes after you inject it, the maximum effect occurs between 1 and 4 hours after the injection, and the effect lasts for up to 14-24 hours.
Estonian: NovoMix 70 veresuhkrut langetav toime algab 10...20 minutit pärast süstimist, saavutab maksimumi 1...4 tunni jooksul pärast süstimist ning kestab 14…24 tundi.
English: INFORMATION IN BRAILLE NovoMix 30 FlexPen
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 30 FlexPen
English: The crystalline phase (50%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin.
Estonian: Kristalliline faas (50%) koosneb protamiiniga kristalliseeritud aspartinsuliinist, mille toime sarnaneb NPH humaaninsuliini toimega.
English: The crystalline phase (30%) consists of protamine-crystallised insulin aspart, which has an activity profile similar to that of human NPH insulin.
Estonian: Kristalliline faas (30%) koosneb protamiiniga kristalliseeritud aspartinsuliinist, mille toime sarnaneb NPH humaaninsuliini toimega.
English: NovoMix 50 FlexPen 100 units/ml suspension for injection in a pre-filled pen 50% soluble insulin aspart and 50% insulin aspart crystallised with protamine
Estonian: NovoMix 50 FlexPen 100 ühikut/ml süstesuspensioon pen-süstlis 50% lahustuvat aspartinsuliini ja 50% protamiiniga kristalliseeritud aspartinsuliini
English: NovoMix 30 Penfill 100 units/ml
Estonian: NovoMix 30 Penfill 100 ühikut/ml
English: NovoMix 70 is administered subcutaneously by injection in the thigh or in the abdominal wall.
Estonian: NovoMix 70 manustatakse naha alla reide või kõhupiirkonda.
English: INFORMATION IN BRAILLE NovoMix 30 Penfill
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 30 Penfill
English: Resuspending your insulin
Estonian: Insuliini resuspendeerimine
English: Patients transferred to NovoMix 70 from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products.
Estonian: Üleminek teiselt insuliinitüübilt NovoMix 70 võib patsiendile kaasa tuua suurema süstide arvu päevas või harjumuspärase insuliiniannuse muutmise.
English: Pack sizes of 1, 5 and 10 cartridges.
Estonian: Pakendi suurused 1, 5 või 10 kolbampulli.
English: NovoMix 50 FlexPen 100 units/ml
Estonian: NovoMix 50 FlexPen 100 ühikut/ml
English: NovoMix 70 FlexPen is only suitable for subcutaneous injections.
Estonian: NovoMix 70 FlexPen on ette nähtud üksnes subkutaanseks süstimiseks.
English: The remaining 70% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin.
Estonian: Ülejäänud 70% on kristallilisel kujul protamiiniga kristalliseeritud aspartinsuliinina; selle imendumisaeg on pikem nagu NPH humaaninsuliinilgi.
English: There are no restrictions on treatment with NovoMix 50 during breast-feeding.
Estonian: Imetamise ajal ei ole piiranguid ravile NovoMix 50.
English: 1 x 3 ml pre-filled pen 5 x 3 ml pre-filled pens 10 x 3 ml pre-filled pens
Estonian: 1 pen-süstel x 3 ml 5 pen-süstlit x 3 ml 10 pen-süstlit x 3 ml
English: INFORMATION IN BRAILLE NovoMix 50 Penfill
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) NovoMix 50 Penfill
English: NovoMix 50 Penfill 100 units/ml
Estonian: NovoMix 50 Penfill 100 ühikut/ml
English: The remaining 50% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin.
Estonian: Ülejäänud 50% on kristallilisel kujul protamiiniga kristalliseeritud aspartinsuliinina; selle imendumisaeg on pikem nagu NPH humaaninsuliinilgi.
English: NovoMix 50 FlexPen Glass ball
Estonian: NovoMix 50 FlexPen Klaas kuul
English: NovoMix 30 FlexPen 100 units/ml
Estonian: NovoMix 30 FlexPen 100 ühikut/ml
English: How to store NovoMix 30
Estonian: Kuidas süstida NovoMix 30
English: Package leaflet: Information for the user NovoMix 70 Penfill 100 units/ml suspension for injection in a cartridge 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine
Estonian: Pakendi infoleht: teave kasutajale NovoMix 70 Penfill 100 Ü/ml süstesuspensioon kolbampullis 70% lahustuvat aspartinsuliini ja 30% protamiiniga kristalliseeritud aspartinsuliini
English: MARKETING AUTHORISATION NUMBERS EU/1/00/142/004 5 cartridges of 3 ml EU/1/00/142/005 10 cartridges of 3 ml
Estonian: MÜÜGILOA NUMBRID EU/1/00/142/004 5 kolbampulli x 3 ml EU/1/00/142/005 10 kolbampulli x 3 ml
English: Patients transferred to NovoMix 30 from another type of insulin may require an increased number of daily injections or a change in dose from that used with their usual insulin medicinal products.
Estonian: Üleminek teiselt insuliinitüübilt NovoMix 30 võib patsiendile kaasa tuua suurema süstide arvu päevas või harjumuspärase insuliiniannuse muutmise.
English: Painful neuropathy (pain due to nerve damage): If your blood sugar level improves very fast, you may get nerve related pain.
Estonian: Kui teie veresuhkru tase paraneb väga kiiresti, siis võib tekkida närvidega seotud valu, mida nimetatakse akuutseks valulikuks neuropaatiaks.
English: NovoMix 70 FlexPen is a pre-filled pen (colour-coded) designed to be used with NovoFine or NovoTwist needles.
Estonian: NovoMix 70 FlexPen on pen-süstel, mis on ette nähtud kasutamiseks koos nõeltega NovoFine või NovoTwist.
English: NovoMix 70 FlexPen 100 units/ml suspension for injection in a pre-filled pen 70% soluble insulin aspart and 30% insulin aspart crystallised with protamine
Estonian: NovoMix 70 FlexPen 100 ühikut/ml süstesuspensioon pen-süstlis 70% lahustuvat aspartinsuliini ja 30% protamiiniga kristalliseeritud aspartinsuliini
English: Store below 30°C Do not freeze
Estonian: Hoida temperatuuril kuni 30 °C.
English: After resuspension, the liquid should appear uniformly white, cloudy and aqueous.
Estonian: Resuspendeeritud vesisuspensioon on ühtlaselt valge ja hägune.
English: The remaining 30% is in crystalline form as protamine-crystallised insulin aspart; this has a prolonged absorption profile similar to human NPH insulin.
Estonian: Ülejäänud 30% on kristallilisel kujul protamiiniga kristalliseeritud aspartinsuliinina; selle imendumisaeg on pikem nagu NPH humaaninsuliinilgi.
English: There are no restrictions on treatment with NovoMix 30 during breast-feeding.
Estonian: Imetamise ajal ei ole piiranguid ravile NovoMix 30.
English: NovoMix 50 FlexPen is only suitable for subcutaneous injections.
Estonian: NovoMix 50 FlexPen on ette nähtud üksnes subkutaanseks süstimiseks.
English: MARKETING AUTHORISATION NUMBERS EU/1/00/142/017 1 cartridge of 3 ml EU/1/00/142/018 5 cartridges of 3 ml EU/1/00/142/019 10 cartridges of 3 ml
Estonian: MÜÜGILOA NUMBRID EU/1/00/142/017 1 kolbampull x 3 ml EU/1/00/142/018 5 kolbampulli x 3 ml EU/1/00/142/019 10 kolbampulli x 3 ml